Kara Olson

2.8k total citations · 2 hit papers
18 papers, 2.1k citations indexed

About

Kara Olson is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kara Olson has authored 18 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kara Olson's work include CAR-T cell therapy research (6 papers), T-cell and B-cell Immunology (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Kara Olson is often cited by papers focused on CAR-T cell therapy research (6 papers), T-cell and B-cell Immunology (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Kara Olson collaborates with scholars based in United States, United Kingdom and Austria. Kara Olson's co-authors include Ralph M. Steinman, Kristin V. Tarbell, Sayuri Yamazaki, Klara Velinzon, Kayo Inaba, Tomonori Iyoda, Madhav V. Dhodapkar, Joseph Krasovsky, Rodney E. Phillips and Sunil Shaunak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Kara Olson

16 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Direct Expansion of Functional CD25+ CD4+ Regulatory T Cells by Antigen-processing Dendritic Cells

2003 697 citations Sayuri Yamazaki, Tomonori Iyoda et al. The Journal of Experimental Medicine profile →
CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune Diabetes

2004 599 citations Kristin V. Tarbell, Sayuri Yamazaki et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kara Olson United States	10	1.7k	401	343	282	237	18	2.1k
Denis Hudrisier France	31	2.3k 1.3×	349 0.9×	126 0.4×	198 0.7×	530 2.2×	54	2.8k
Jeannine Choppin France	26	1.2k 0.7×	245 0.6×	344 1.0×	299 1.1×	522 2.2×	56	1.7k
Maria Bettinotti United States	25	1.4k 0.8×	473 1.2×	675 2.0×	182 0.6×	404 1.7×	52	2.2k
Maggi Pack United States	16	2.2k 1.3×	507 1.3×	186 0.5×	95 0.3×	451 1.9×	18	2.5k
Monika Srivastava Australia	7	2.4k 1.4×	354 0.9×	114 0.3×	154 0.5×	362 1.5×	9	2.8k
Yik Y. L. Yu United States	17	1.6k 0.9×	516 1.3×	75 0.2×	208 0.7×	403 1.7×	20	2.0k
Katharina Willimann Switzerland	12	2.4k 1.4×	835 2.1×	101 0.3×	110 0.4×	239 1.0×	14	2.8k
Roberto De Pascalis United States	18	721 0.4×	445 1.1×	101 0.3×	149 0.5×	531 2.2×	32	1.4k
Frank Mortari United States	18	913 0.5×	196 0.5×	269 0.8×	67 0.2×	344 1.5×	24	1.4k
A I Lazarovits Canada	21	1.2k 0.7×	156 0.4×	87 0.3×	239 0.8×	253 1.1×	41	1.9k

Countries citing papers authored by Kara Olson

Since Specialization

Citations

This map shows the geographic impact of Kara Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara Olson more than expected).

Fields of papers citing papers by Kara Olson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kara Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara Olson. The network helps show where Kara Olson may publish in the future.

Co-authorship network of co-authors of Kara Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Kara Olson. A scholar is included among the top collaborators of Kara Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kara Olson. Kara Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Olson, Kara, David J. DiLillo, Olga Sineshchekova, et al.. (2024). A CD38xCD28 Costimulatory Bispecific Antibody Demonstrates Potent Preclinical Combinatorial Activity with a BCMAxCD3 T Cell-Engager. Blood. 144(Supplement 1). 3283–3283. 1 indexed citations

Lee, Ken-Wing, Yi Zhou, Matthew C. Franklin, et al.. (2024). Characterization of Linvoseltamab's BCMA Binding Epitope and Efficacy Against BCMA Mutations in Relapsed/Refractory Multiple Myeloma. Blood. 144(Supplement 1). 3265–3265. 7 indexed citations

Mastrangelo, Christina M. & Kara Olson. (2024). A reliability approach for prediction and management of part obsolescence for improved system health. Quality Engineering. 36(1). 181–190.

Zhu, Min, Kara Olson, Jessica R. Kirshner, et al.. (2022). Translational findings for odronextamab: From preclinical research to a first‐in‐human study in patients with CD20+ B‐cell malignancies. Clinical and Translational Science. 15(4). 954–966. 11 indexed citations

DiLillo, David J., Kara Olson, Katja Mohrs, et al.. (2021). A BCMAxCD3 bispecific T cell–engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cells. Blood Advances. 5(5). 1291–1304. 38 indexed citations

Mastrangelo, Christina M., et al.. (2021). A risk-based approach to forecasting component obsolescence. Microelectronics Reliability. 127. 114330–114330. 7 indexed citations

Hauser, R., Mark Lew, Cynthia L. Comella, et al.. (2020). Nighttime and morning OFF improvements with opicapone in patients with Parkinson's Disease and motor fluctuations: BIPARK-1 and BIPARK-2 pooled subanalyses. Parkinsonism & Related Disorders. 79. e53–e54. 2 indexed citations

DiLillo, David J., Kara Olson, Katja Mohrs, et al.. (2018). REGN5458, a Bispecific BCMAxCD3 T Cell Engaging Antibody, Demonstrates Robust In Vitro and In Vivo Anti-Tumor Efficacy in Multiple Myeloma Models, Comparable to That of BCMA CAR T Cells. Blood. 132(Supplement 1). 1944–1944. 14 indexed citations

Smith, Eric, Kara Olson, Lauric Haber, et al.. (2015). A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys. Scientific Reports. 5(1). 17943–17943. 122 indexed citations

10.

Varghese, Bindu, Jayanthi Menon, Luis Rodríguez, et al.. (2015). CD20xCD3 Bispecific Fully Human Antibody Induces Potent Anti-Tumor Activity Against CD20-Expressing Tumors in Immune Competent Mice Humanized for CD20 and CD3. Blood. 126(23). 818–818.

11.

Varghese, Bindu, Jayanthi Menon, Luis Rodríguez, et al.. (2014). A Novel CD20xCD3 Bispecific Fully Human Antibody Induces Potent Anti-Tumor Effects Against B Cell Lymphoma in Mice. Blood. 124(21). 4501–4501. 4 indexed citations

12.

Billiard, Fabienne, Jessica R. Kirshner, Wen Zhang, et al.. (2011). Ongoing Dll4‐Notch signaling is required for T‐cell homeostasis in the adult thymus. European Journal of Immunology. 41(8). 2207–2216. 16 indexed citations

13.

Fuller, Jessica, et al.. (2005). DR.lyp/lyp bone marrow maintains lymphopenia and promotes diabetes in lyp/lyp but not in +/+ recipient DR.lyp BB rats. Journal of Autoimmunity. 25(4). 251–257. 6 indexed citations

14.

Tarbell, Kristin V., et al.. (2004). CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune Diabetes. The Journal of Experimental Medicine. 199(11). 1467–1477. 599 indexed citations breakdown →

15.

Yamazaki, Sayuri, Tomonori Iyoda, Kristin V. Tarbell, et al.. (2003). Direct Expansion of Functional CD25+ CD4+ Regulatory T Cells by Antigen-processing Dendritic Cells. The Journal of Experimental Medicine. 198(2). 235–247. 697 indexed citations breakdown →

16.

Dhodapkar, Madhav V., Joseph Krasovsky, & Kara Olson. (2002). T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells. Proceedings of the National Academy of Sciences. 99(20). 13009–13013. 129 indexed citations

17.

Kelleher, Anthony D., Edward C. Holmes, Rachel Allen, et al.. (2001). Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses. The Journal of Experimental Medicine. 193(3). 375–386. 360 indexed citations

18.

Purbhoo, Marco A., Jonathan M. Boulter, David A. Price, et al.. (2001). The Human CD8 Coreceptor Effects Cytotoxic T Cell Activation and Antigen Sensitivity Primarily by Mediating Complete Phosphorylation of the T Cell Receptor ζ Chain. Journal of Biological Chemistry. 276(35). 32786–32792. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact